These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate. Lapadula DM; Patton SE; Campbell GA; Abou-Donia MB Toxicol Appl Pharmacol; 1985 Jun; 79(1):83-90. PubMed ID: 4049409 [TBL] [Abstract][Full Text] [Related]
3. Time course of the tri-o-cresyl phosphate-induced testicular lesion in F-344 rats: enzymatic, hormonal, and sperm parameter studies. Somkuti SG; Lapadula DM; Chapin RE; Lamb JC; Abou-Donia MB Toxicol Appl Pharmacol; 1987 Jun; 89(1):64-72. PubMed ID: 3590189 [TBL] [Abstract][Full Text] [Related]
4. Brain acetylcholinesterase, acid phosphatase, and 2',3'-cyclic nucleotide-3'-phosphohydrolase and plasma butyrylcholinesterase activities in hens treated with a single dermal neurotoxic dose of S,S,S-tri-n-butyl phosphorotrithioate. Abou-Donia MB; Abdo KM; Timmons PR; Proctor JE Toxicol Appl Pharmacol; 1986 Mar; 82(3):461-73. PubMed ID: 3952729 [TBL] [Abstract][Full Text] [Related]
5. Reproductive tract lesions resulting from subchronic administration (63 days) of tri-o-cresyl phosphate in male rats. Somkuti SG; Lapadula DM; Chapin RE; Lamb JC; Abou-Donia MB Toxicol Appl Pharmacol; 1987 Jun; 89(1):49-63. PubMed ID: 3590188 [TBL] [Abstract][Full Text] [Related]
6. Lack of delayed neurotoxic effect after tri-o-cresyl phosphate treatment in male Fischer 344 rats: biochemical, neurobehavioral, and neuropathological studies. Somkuti SG; Tilson HA; Brown HR; Campbell GA; Lapadula DM; Abou-Donia MB Fundam Appl Toxicol; 1988 Feb; 10(2):199-205. PubMed ID: 3356306 [TBL] [Abstract][Full Text] [Related]
7. The effect of a single oral dose of tri-o-cresyl phosphate on neurotoxic esterase and acetylcholinesterase activities in the central nervous system, erythrocytes and plasma. Barrett DS; Oehme FW Vet Hum Toxicol; 1994 Feb; 36(1):1-4. PubMed ID: 8154093 [TBL] [Abstract][Full Text] [Related]
8. Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate. Carrington CD; Abou-Donia MB J Toxicol Environ Health; 1988; 25(3):259-68. PubMed ID: 3184197 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the delayed neurotoxicity of tributyl phosphate, tributoxyethyl phosphate, and dibutylphenyl phosphate. Carrington CD; Lapadula DM; Othman M; Farr C; Nair RS; Johannsen F; Abou-Donia MB Toxicol Ind Health; 1990; 6(3-4):415-23. PubMed ID: 2237927 [TBL] [Abstract][Full Text] [Related]
11. Biochemical, histopathological and clinical evaluation of delayed effects caused by methamidophos isoforms and TOCP in hens: ameliorative effects using control of calcium homeostasis. Emerick GL; Ehrich M; Jortner BS; Oliveira RV; Deoliveira GH Toxicology; 2012 Dec; 302(1):88-95. PubMed ID: 22974967 [TBL] [Abstract][Full Text] [Related]
12. Organophosphate induced delayed neuropathy in genetically dissimilar chickens: studies with tri-ortho-cresyl phosphate (TOCP) and trichlorfon. Honorato de Oliveira G; Moreira V; Ribeiro Goes SP Toxicol Lett; 2002 Dec; 136(2):143-50. PubMed ID: 12425964 [TBL] [Abstract][Full Text] [Related]
13. The interaction of Sertoli and Leydig cells in the testicular toxicity of tri-o-cresyl phosphate. Chapin RE; Phelps JL; Somkuti SG; Heindel JJ; Burka LT Toxicol Appl Pharmacol; 1990 Jul; 104(3):483-95. PubMed ID: 2385838 [TBL] [Abstract][Full Text] [Related]
15. Is delayed neurotoxicity a property of all organophosphorus compounds? A study with a model compound: parathion. Soliman SA; Farmer J; Curley A Toxicology; 1982; 23(4):267-79. PubMed ID: 7123563 [TBL] [Abstract][Full Text] [Related]
16. Induction of hepatic microsomal cytochrome P-450 and inhibition of brain, liver, and plasma esterases by an acute dose of S,S,S-tri-n-butyl phosphorotrithioate (DEF) in the adult hen. Lapadula DM; Carrington CD; Abou-Donia MB Toxicol Appl Pharmacol; 1984 Apr; 73(2):300-10. PubMed ID: 6710530 [TBL] [Abstract][Full Text] [Related]
17. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques. Hausherr V; Schöbel N; Liebing J; van Thriel C Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic changes following treatment with organophosphorus-induced delayed neuropathy-producing agents in the adult hen. Robertson DG; Schwab BW; Sills RD; Richardson RJ; Anderson RJ Toxicol Appl Pharmacol; 1987 Mar; 87(3):420-9. PubMed ID: 3564017 [TBL] [Abstract][Full Text] [Related]
19. The effects of drug metabolism inducers on the delayed neurotoxicity and disposition of tri-o-cresyl phosphate in hens following a single intravenous administration. Konno N; Katoh K; Yamauchi T; Fukushima M J Toxicol Sci; 1988 Feb; 13(1):17-30. PubMed ID: 3385808 [TBL] [Abstract][Full Text] [Related]
20. Time-dependent changes of lipid peroxidation and antioxidative status in nerve tissues of hens treated with tri-ortho-cresyl phosphate (TOCP). Zhang LP; Wang QS; Guo X; Zhu YJ; Zhou GZ; Xie KQ Toxicology; 2007 Sep; 239(1-2):45-52. PubMed ID: 17662514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]